Clinical trial
Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With…
NCT00090558 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00090558 |
|---|---|
| Title | Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease |
| Official title | Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | nitroglycerin |
| Enrollment | 30 |
| Start date | Aug 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Aug 27, 2004 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: